 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Laura Hutchins and Ronda Henry-Tillman.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.298 |
|
|
|
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
Score: 0.135
-
Starlard-Davenport A, Glover-Collins K, Mahkoul I, Hutchins L, Westbrook K, Korourian S, Enoch K, Preston M, Jackson SN, Klimberg VS, Henry-Tillman R. Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review. Springerplus. 2013; 2:516.
Score: 0.124
-
Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. PLoS One. 2017; 12(1):e0168550.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|